BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19017177)

  • 1. Inflammatory cells and immune microenvironment in malignant lymphoma.
    de Jong D; Enblad G
    J Intern Med; 2008 Dec; 264(6):528-36. PubMed ID: 19017177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.
    Aldinucci D; Gloghini A; Pinto A; De Filippi R; Carbone A
    J Pathol; 2010 Jul; 221(3):248-63. PubMed ID: 20527019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokines and malignant lymphomas].
    Feller AC; Merz H
    Verh Dtsch Ges Pathol; 1992; 76():70-8. PubMed ID: 1283279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
    Muenst S; Hoeller S; Dirnhofer S; Tzankov A
    Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunodeficiency and lymphomas].
    Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
    G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
    [No Abstract]   [Full Text] [Related]  

  • 7. The Germinal centre-derived lymphomas seen through their cellular microenvironment.
    Carbone A; Gloghini A; Cabras A; Elia G
    Br J Haematol; 2009 May; 145(4):468-80. PubMed ID: 19344401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune responses and prognosis in malignant lymphomas.
    Sokal JE; Aungst CW
    Natl Cancer Inst Monogr; 1971 Dec; 34():109-12. PubMed ID: 4946576
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pathophysiology of malignant lymphoma from the hematological point of view. 3. Changes in peripheral blood lymphocyte count and the recovery of cell-mediated immune function after therapy of T-, B-malignant lymphomas and Hodgkin's disease].
    Kinoshita K; Amagasaki T; Momita S; Ikeda S; Ichimaru M; Kamihira S
    Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1068-80. PubMed ID: 3788434
    [No Abstract]   [Full Text] [Related]  

  • 10. [Culture of peripheral lymphocytes in chronic malignant lymphoadenopathies].
    Giraudo Conesa LC; Braun M; Bachmann AE; Pavlovsky A
    Prensa Med Argent; 1971 Aug; 58(23):1160-2. PubMed ID: 4940640
    [No Abstract]   [Full Text] [Related]  

  • 11. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
    Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
    Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma.
    Enblad G; Molin D; Glimelius I; Fischer M; Nilsson G
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):805-23. PubMed ID: 17908621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.
    Liu Y; Sattarzadeh A; Diepstra A; Visser L; van den Berg A
    Semin Cancer Biol; 2014 Feb; 24():15-22. PubMed ID: 23867303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral cross immunity in patients with malignant tumors.
    Harlozinska A; Albert Z; Richter R; Singer Z; Salwa J
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):835-49. PubMed ID: 4946994
    [No Abstract]   [Full Text] [Related]  

  • 15. The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC.
    Hnátková M; Mociková H; Trnený M; Zivný J
    Prague Med Rep; 2009; 110(1):35-41. PubMed ID: 19591376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulative lymphoma theory revisited; what can we learn from cytokines, CD classes and genes?
    Krueger GR; Nguyen AN; Uthman M; Brandt ME; Buja LM
    Anticancer Res; 2001; 21(5):3653-61. PubMed ID: 11848539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tentative pathogenetic interpretation of some cytoimmunological aspects in malignant lymphomas, with particular reference to Hodgkin's disease.
    Mauri C; Quaglino D; De Pasquale A
    Haematologica; 1979 Dec; 64(6):826-44. PubMed ID: 121095
    [No Abstract]   [Full Text] [Related]  

  • 19. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients.
    Kindlund B; Sjöling A; Hansson M; Edebo A; Hansson LE; Sjövall H; Svennerholm AM; Lundin BS
    Helicobacter; 2009 Jun; 14(3):192-201. PubMed ID: 19702849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse aggressive B-cell lymphomas.
    Said J
    Adv Anat Pathol; 2009 Jul; 16(4):216-35. PubMed ID: 19546610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.